The U.S. disposable syringes market size was exhibited at USD 3.43 billion in 2023 and is projected to hit around USD 5.83 billion by 2033, growing at a CAGR of 5.44% during the forecast period 2024 to 2033.
| Report Coverage | Details |
| Market Size in 2024 | USD 3.62 Billion |
| Market Size by 2033 | USD 5.83 Billion |
| Growth Rate From 2024 to 2033 | CAGR of 5.44% |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Segments Covered | Product, Application |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional Scope | U.S. |
| Key Companies Profiled | Medtronic; Nipro Corp.; Fresenius Kabi AG; Baxter; Braun Medical, Inc.; Becton, Dickinson and Company (BD); Flextronics International Vita Needle Company; Terumo Corp.; Novo Nordisk; Ultimed, Inc.; Henke-Sass Wolf; Retractable Technologies, Inc. |
The rapid increase in prevalence of chronic illnesses,growing number of surgeries, and increasing adoption of safety syringes are significantly driving the market growth. In 2023, U.S. disposable syringes market accounted for over 27% of the global disposable syringes market. Increasing investments by governments, growing R&D activities, rising prevalence of chronic diseases such as diabetes & cancer, and presence of key companies are among the factors driving the market growth.
Need for disposable syringes in different healthcare settings is projected to surge with the increasing geriatric population, a demographic that is highly vulnerable to chronic disorders including diabetes and other lifestyle-associated health conditions. In addition, according to the CDC, population base aged 65 years and above are more likely to acquire diabetes, heart disease, cancer, COPS, neurological problems, and other chronic conditions. Patients with such illnesses require emergency and non-emergency hospital services which are likely to boost the market growth in the upcoming years.
Rise in number of government initiatives aimed at ensuring the highest level of infection prevention is expected to create opportunities for market growth. Both the U.S. government and organizations such as the World Health Organization (WHO) and United Nations Programme on HIV/AIDS (UNAIDS) have implemented numerous initiatives to promote safe drug delivery. Some of the programs conducted by these organizations are needle and syringe programs; prevention & treatment of sexually transmitted infections; targeted information; and education & communication for people who abuse drugs and their sexual partners. To address safety issues, the government mandated the use of safety engineered devices in healthcare facilities.
The industry is currently in a medium growth stage (CAGR: 5-10%). Moreover, the pace of growth indicates an accelerating trend. Syringes are required for numerous diagnostic and therapeutic approaches for chronic diseases as they play a crucial role during medication administration and tests, resulting in rising demand for the product. A huge percentage of the U.S. population is currently at danger of developing chronic diseases, as a result of high blood pressure, obesity, smoking, diabetes, sedentary lifestyle and excessive alcohol consumption.
Technological breakthroughs such as improvement in design and safety technology aimed at improving functionality and efficacy offer significant opportunities for companies. For instance, in October 2022, Terumo Pharmaceutical Solutions, a manufacturer of primary container, injection, and infusion therapy devices, announced the launch of a polymer ready-to-fill syringe for use in larger volume biotech drugs.
The disposable syringes industry is characterized by a high level of M&A activities undertaken by leading companies. This is due to factors including the increasing focus on enhancing companies' portfolio and the need to consolidate in a rapidly growing industry. Several companies are undertaking this strategy to strengthen their portfolio. For instance, in January 2022, ICU Medical Inc. announced the completion of the acquisition of Smiths Medical. The business areas of Smiths Medical includes syringes, ambulatory infusion devices, vital care products, and vascular access.
Presence of robust healthcare institutions as well as political bills such as, the Healthcare Reform Bill is expected to drive the sale of disposable syringes and other basic medical supplies. Syringes and other medical devices used to inject medications into the body are regulated by FDA. This includes insulin delivery systems, injectable drugs, and other medical treatments. The FDA guarantees that these devices are both safe and effective in their intended use. Syringes are classified as Class II medical device. A syringe must meet specific safety and quality requirements set by the FDA in order to be approved. The approval process is intended to assure the sale of only safe and effective syringes in the country.
The safety syringes held the largest market share of 64.5% in 2023.Safety syringes eliminate the risk of patient-to-patient infections transmission, due to which these syringes are likely to retain its dominance throughout the forecast period. These syringes are primarily used for administering medications with the help of specialized and standard techniques. Unsafe practices including multiple use of a needle and syringe without precautionary measures can cause needle stick injuries.
The WHO has issued guidelines for the use of safety syringes to prevent needlestick injuries. The main aim of these guidelines is to prevent the reuse of conventional syringes. The International Organization for Standardization (ISO) has also issued a set of requirements for manufacturers of safety syringes to ensure safety and high performance level of the products. Such safety mandates are projected to be opportunistic for the product demand.
The therapeutic injections led the market and accounted for 86.0% share in 2023. Increasing awareness about blood donations is among the significant factors driving the product demand. Injections are used in almost every medical procedure, from diagnosis to treatment. Increasing prevalence of diseases including malaria, tuberculosis, AIDS, and dengue leads to increasing need for injections as they are among the essential requirements for diagnosis and treatment.
The immunization injections segment is projected to exhibit the fastest growth over the forecast period. Vaccination drive is primarily a mass activity, which can thereby increase the risk associated with contamination from blood-borne pathogens. In these cases, the multiple use of needles and syringes is to be prevented to avoid the risk of needle stick injuries. Furthermore, the type of injections used also depends on the cost, safety, and type of vaccine to be administered. Prefilled auto-disable syringes are mainly preferred, provided all the vaccines are available in the same form. This prevents contamination, increases the dosage accuracy, and reduces the waste generated from a large number of vials.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the U.S. disposable syringes market
Product
Application
Chapter 1 Methodology and Scope
1.1 Market Segmentation And Scope
1.1.1 Product
1.1.2 Application
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.7.1 Commodity Flow Analysis (Model 1)
1.7.1.1 Approach 1: Commodity Flow Approach
1.7.2 Volume Price Analysis (Model 2)
1.7.2.1 Approach 2: Volume Price Analysis
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective - 1
1.10.2 Objective - 2
1.10.3 Objective - 3
1.10.4 Objective - 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Disposable Syringes Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer Behavior Analysis
3.3.2 Market Influencer Analysis
3.4 List Of Key End Users
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Increase In The Prevalence Of Chronic Diseases
3.5.1.2 Increase In The Number Of Surgical Procedures
3.5.1.3 Impact Of Covid-19 Outbreak
3.5.1.4 Increasing Initiatives By Governments And Organizations
3.5.2 Market Restraints Analysis
3.5.2.1 Stringent Government Regulations
3.5.2.2 Product Recalls
3.6 Disposable Syringes: Market Analysis Tools
3.6.1 Industry Analysis - Porter’s Five Forces
3.6.2 Swot Analysis, By Pest
3.7 Impact Of Covid-19 On Market & Post Pandemic Insights
Chapter 4 U.S. Disposable Syringes Market: Segment Analysis, By Product, 2021 - 2033
4.1 Definition And Scope
4.2 Product Market Share Analysis, 2024 & 2033
4.3 Segment Dashboard
4.4 U.S. Disposable Syringes Market, By Product, 2021 To 2033
4.5 Market Size & Forecasts And Trend Analyses, 2021 To 2033
4.5.1 Conventional Syringes
4.5.1.1 Conventional Syringes Market, 2021 - 2033
4.5.2 Safety Syringes
4.5.2.1 Safety Syringes Market, 2021 - 2033
4.5.2.1.1 Retractable Safety Syringes
4.5.2.1 1.1 Retractable Safety Syringes Market, 2021 - 2033
4.5.2.1.2 Non-retractable Safety Syringes
4.5.2.1.2.1 Non-retractable Safety Syringes Market, 2021 - 2033
Chapter 5 U.S. Disposable Syringes Market: Segment Analysis, By Application, 2021 - 2033
5.1 Definition And Scope
5.2 Application Market Share Analysis, 2024 & 2033
5.3 Segment Dashboard
5.4 U.S. Disposable Syringes Market, By Application, 2021 To 2033
5.5 Market Size & Forecasts And Trend Analyses, 2021 To 2033
5.5.1 Immunization Injections
5.5.1.1 Immunization Injections Market, 2021 - 2033
5.5.2 Therapeutic Injections
5.5.2.1 Therapeutic Injections Market, 2021 - 2033
Chapter 6 U.S. Disposable Syringes Market - Competitive Analysis
6.1 Recent Developments & Impact Analysis, By Key Market Participants
6.2 Company Categorization
6.2.1 Innovators
6.2.2 Market Leaders
6.3 Vendor Landscape
6.3.1 Key Company Market Share Analysis, 2021
6.3.2 Major Deals And Strategic Alliances
6.3.2.1 New Product Launch
6.3.2.2 Expansion
6.3.2.3 Acquistion
6.3.3 Market Entry Strategies
6.4 Company Profiles
6.4.1 Medtronic
6.4.1.1 Company Overview
6.4.1.2 Financial Performance
6.4.1.3 Product Benchmarking
6.4.1.4 Strategic Initiatives
6.4.2 Nipro Corporation
6.4.2.1 Company Overview
6.4.2.2 Financial Performance
6.4.2.3 Product Benchmarking
6.4.2.4 Strategic Initiatives
6.4.3 Fresenius Kabi Ag
6.4.3.1 Company Overview
6.4.3.2 Financial Performance
6.4.3.3 Product Benchmarking
6.4.3.4 Strategic Initiatives
6.4.4 Baxter International, Inc.
6.4.4.1 Company Overview
6.4.4.2 Financial Performance
6.4.4.3 Product Benchmarking
6.4.4.4 Strategic Initiatives
6.4.5 Braun Medical, Inc.
6.4.5.1 Company Overview
6.4.5.2 Financial Performance
6.4.5.3 Product Benchmarking
6.4.5.4 Strategic Initiatives
6.4.6 Becton, Dickinson And Company (Bd)
6.4.6.1 Company Overview
6.4.6.2 Financial Performance
6.4.6.3 Product Benchmarking
6.4.6.4 Strategic Initiatives
6.4.7 Flextronics International Vita Needle Company
6.4.7.1 Company Overview
6.4.7.2 Financial Performance
6.4.7.3 Product Benchmarking
6.4.7.4 Strategic Initiatives
6.4.8 Terumo Corporation
6.4.8.1 Company Overview
6.4.8.2 Financial Performance
6.4.8.3 Product Benchmarking
6.4.8.4 Strategic Initiatives
6.4.9 Novo Nordisk
6.4.9.1 Company Overview
6.4.9.2 Financial Performance
6.4.9.3 Product Benchmarking
6.4.9.4 Strategic Initiatives
6.4.10 Ultimed, Inc.
6.4.10.1 Company Overview
6.4.10.2 Financial Performance
6.4.10.3 Product Benchmarking
6.4.10.4 Strategic Initiatives
6.4.11 Henke-sass, Wolf
6.4.11.1 Company Overview
6.4.11.2 Financial Performance
6.4.11.3 Product Benchmarking
6.4.12.4 Retractable Technologies, Inc.
6.4.12.1 Company Overview
6.4.12.2 Financial Performance
6.4.12.3 Product Benchmarking
6.4.12.4 Strategic Initiatives
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers